Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12997248 | 0.81 | ADRB2 (0.42) | ADRB2ADRB1ADRB3THRB | |
| SCHEMBL1701153 | 0.81 | ALDH1A1 (0.39) | THRBLMNA | |
| SCHEMBL31079405 | 0.78 | THRB (0.40) | THRBLMNA | |
| SCHEMBL5666168 | 0.76 | THRB (0.50) | THRBLMNA | |
| SCHEMBL8588639 | 0.76 | THRB (0.38) | THRBLMNA | |
| SCHEMBL13639438 | 0.75 | — | — | |
| SCHEMBL18042684 | 0.74 | THRB (0.36) | THRBLMNA | |
| SCHEMBL15577252 | 0.74 | THRB (0.36) | THRBLMNA | |
| SCHEMBL366440 | 0.72 | THRB (0.40) | THRBLMNA | |
| SCHEMBL9695937 | 0.72 | THRB (0.40) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130230898-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-20130230898-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8404834-B2 | Hydroxyalkyl starch derivatives and process for their preparation | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-03-26 | — | — | US | disclosed |
| US-8404834-B2 | Hydroxyalkyl starch derivatives and process for their preparation | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-03-26 | — | — | US | disclosed |
| US-20100305033-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2010-12-02 | — | — | US | disclosed |
| US-20100305033-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2010-12-02 | — | — | US | disclosed |
| US-7799913-B2 | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses | CORTEX PHARMACEUTICALS, INC. (US) | 2010-09-21 | — | — | US | disclosed |
| US-20040259871-A1 | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses | CORTEX PHARMACEUTICALS, INC | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259871-A1 | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses | GAP43, GRIN2B, GRIN2A | ADRB2 590/4885ADRB1 852/4885ADRB3 979/4885 |
| US-20100305033-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | HDHD5, KHK, SORD | ADRB2 4253/4885ADRB1 3840/4885ADRB3 3536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.